Background illustration for clinical trials search

Sarcoma Clinical Trials

Browse 918 sarcoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

for
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma,
Location: Boston MA, Philadelphia PA, Charlottesville VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT04104776

Phase1, Phase2, Recruiting

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

for
Leukemia, Acute Leukemia, Acute Lymphoid Leukemia,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 6+

Code: NCT07634653

Recruiting

Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma

for
Large B-cell Lymphoma, Relapse
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06919939

Phase2, Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

for
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer,
Location: Montreal
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07468071

Phase1, Phase2, Recruiting

Precise Oncology Interventions in Nutrition and Training (OnPoint)

for
Breast Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06534918

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

for
Marginal Zone Lymphoma,
Location: Miami FL
Sponsor: Izidore Lossos, MD

Sex: All

Age: 18+

Code: NCT06796998

Phase2, Recruiting

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

for
T-cell-prolymphocytic Leukemia,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06810778

Phase1, Phase2, Recruiting

XL092 and Cemiplimab in BRAF WT Thyroid Cancer

for
Anaplastic Thyroid Cancer, Thyroid Cancer,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06902376

Phase1, Recruiting

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

for
Glioblastoma, Glioblastoma, IDH-Wildtype, Gliosarcoma,
Location: Los Angeles CA
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07089641

Phase1, Recruiting

Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

for
Relapsed CLL, Refractory CLL, Refractory Lymphoma
Location: Cleveland OH
Sponsor: Paolo Caimi, MD

Sex: All

Age: 18+

Code: NCT06916767

Phase1, Recruiting

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration,
Location: New York NY
Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All

Age: 18+

Code: NCT06716138

Phase1, Recruiting

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

for
Lymphoma
Location: Commack NY, Uniondale NY, East White Plains NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT02974647

Phase2, Recruiting

Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ΞΆ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)

for
Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL,
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 2 - 70

Code: NCT03938987

Phase1, Phase2, Recruiting

IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL

for
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT06768905

Phase1, Phase2, Recruiting

Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
Non-Hodgkin Lymphoma, B-cell Acute Lymphoblastic Leukemia,
Location: Boston MA, Providence RI, New York NY, Baltimore MD,
Sponsor: Imugene Limited

Sex: All

Age: 18+

Code: NCT03666000

Phase1, Recruiting

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

for
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT01137643

Recruiting

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

for
Mantle Cell Lymphoma, Follicular Lymphoma,
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT04223765

Phase1, Recruiting

Pediatric PET/MR Image Registry

for
Soft Tissue, Lymphoma, Osteosarcoma
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 0 - 40

Code: NCT03458520

Recruiting